Aprogen Healthcare & Games Inc (KQ:109960) — Market Cap & Net Worth

$219.79 Million USD  · ₩324.33 Billion KRW  · Rank #16290

Market Cap & Net Worth: Aprogen Healthcare & Games Inc (109960)

Aprogen Healthcare & Games Inc (KQ:109960) has a market capitalization of $219.79 Million (₩324.33 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #16290 globally and #586 in its home market, demonstrating a -4.42% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aprogen Healthcare & Games Inc's stock price ₩1815.00 by its total outstanding shares 178695008 (178.70 Million). Also see Aprogen Healthcare & Games Inc total assets for a full breakdown of the balance sheet.

Aprogen Healthcare & Games Inc Market Cap History: 2015 to 2026

Aprogen Healthcare & Games Inc's market capitalization history from 2015 to 2026. Data shows change from $1.90 Billion to $219.79 Million (-18.84% CAGR). Also see Aprogen Healthcare & Games Inc cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

Aprogen Healthcare & Games Inc is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
Kosdaq Composite Index
KOSDAQ
$234.31 Billion 0.09% #198 of 1384
Kosdaq Composite Index
KQ11
$234.31 Billion 0.09% #198 of 1384

Weight: Aprogen Healthcare & Games Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Aprogen Healthcare & Games Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Aprogen Healthcare & Games Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 109960 live share price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.00x

Aprogen Healthcare & Games Inc's market cap is 0.00 times its annual revenue

Industry average: 0.00x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $1.90 Billion $11.12 Billion -$2.56 Billion 0.17x N/A
2016 $1.64 Billion $9.82 Billion -$22.75 Billion 0.17x N/A
2017 $980.90 Million $11.24 Billion -$3.30 Billion 0.09x N/A
2018 $445.04 Million $17.58 Billion $8.74 Billion 0.03x 0.05x
2019 $502.56 Million $21.90 Billion -$6.75 Billion 0.02x N/A
2020 $449.28 Million $10.32 Billion $11.08 Billion 0.04x 0.04x
2021 $424.45 Million $8.42 Billion $2.65 Billion 0.05x 0.16x
2022 $227.06 Million $9.60 Billion -$5.61 Billion 0.02x N/A
2023 $94.34 Million $16.01 Billion $4.30 Billion 0.01x 0.02x
2024 $63.09 Million $16.40 Billion -$28.09 Billion 0.00x N/A

Competitor Companies of 109960 by Market Capitalization

Companies near Aprogen Healthcare & Games Inc in the global market cap rankings as of September 18, 2026. Review Aprogen Healthcare & Games Inc (109960) tangible net worth to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Aprogen Healthcare & Games Inc by market ranking:

  • Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5605 globally with a market cap of $2.37 Billion USD ( ₩3.50 Trillion KRW).
  • ST Pharm Co.Ltd (KQ:237690): Ranked #8267 globally with a market cap of $1.16 Billion USD ( ₩1.71 Trillion KRW).
  • NatureCell Co.Ltd (KQ:007390): Ranked #9464 globally with a market cap of $884.84 Million USD ( ₩1.31 Trillion KRW).
  • Oscotec Inc (KQ:039200): Ranked #10523 globally with a market cap of $713.20 Million USD ( ₩1.05 Trillion KRW).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#5605 Sam Chun Dang Pharm. Co. Ltd KQ:000250 $2.37 Billion ₩163500.00
#8267 ST Pharm Co.Ltd KQ:237690 $1.16 Billion ₩91900.00
#9464 NatureCell Co.Ltd KQ:007390 $884.84 Million ₩24600.00
#10523 Oscotec Inc KQ:039200 $713.20 Million ₩37450.00

Aprogen Healthcare & Games Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, Aprogen Healthcare & Games Inc's market cap moved from $1.90 Billion to $ 219.79 Million, with a yearly change of -18.84%.

Year Market Cap Change (%)
2026 ₩219.79 Million +626.00%
2025 ₩30.27 Million -52.02%
2024 ₩63.09 Million -33.12%
2023 ₩94.34 Million -58.45%
2022 ₩227.06 Million -46.50%
2021 ₩424.45 Million -5.53%
2020 ₩449.28 Million -10.60%
2019 ₩502.56 Million +12.93%
2018 ₩445.04 Million -54.63%
2017 ₩980.90 Million -40.33%
2016 ₩1.64 Billion -13.40%
2015 ₩1.90 Billion --

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of Aprogen Healthcare & Games Inc was reported to be:

Source Market Cap
Yahoo Finance $219.79 Million USD
MoneyControl $219.79 Million USD
MarketWatch $219.79 Million USD
marketcap.company $219.79 Million USD
Reuters $219.79 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Aprogen Healthcare & Games Inc

KQ:109960 Korea Pharmaceuticals
Market Cap
$219.79 Million
₩324.33 Billion KRW
Market Cap Rank
#16290 Global
#586 in Korea
Share Price
₩1815.00
Change (1 day)
-0.98%
52-Week Range
₩150.00 - ₩2300.00
All Time High
₩20250.00
About

Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more